Clinical Trials Logo

Myopia clinical trials

View clinical trials related to Myopia.

Filter by:

NCT ID: NCT05656885 Completed - Myopia Clinical Trials

Clinical Evaluation of Two Frequent Replacement Soft Spherical Contact Lenses

Start date: September 27, 2022
Phase: N/A
Study type: Interventional

This was a single-blind (participant masked), interventional, prospective, direct refit, bilateral wear short-term fitting study.

NCT ID: NCT05650190 Completed - Myopia Clinical Trials

Spectacle Lens Visual Acuity Assessments Study

CEDAR
Start date: December 8, 2022
Phase: N/A
Study type: Interventional

This is a two-arm parallel group, non-dispensing study. Participants will be existing active CYPRESS Extension (CPRO-1802-002) subjects. Subjects will undergo additional visual performance assessments.

NCT ID: NCT05635526 Completed - Myopia Clinical Trials

Assessment of Corneal Biomechanics With the Corvis ST in Different Age of Myopia With Orthokeratology

Start date: June 1, 2020
Phase:
Study type: Observational

The present research focused on the effect of the age for the corneal biomechanics of low and moderate myopia patients after wearing orthokeratology (OK lens). According to age, the included cases were divided into 3 groups. Through the analysis of corneal biomechanical parameters, further learn the influence of OK lens on the patient cornea. It would help ophthalmologist and optometrist find out the potential issue and reach a better control result.

NCT ID: NCT05594732 Completed - Myopia Clinical Trials

The Effects of Different Outdoor Light Exposure Modes on Retinal Blood Flow

Start date: September 6, 2022
Phase: N/A
Study type: Interventional

In 2020, the overall myopia rate among children and adolescents in my country was 52.7%. The COVID-19 pandemic has increased students' time of indoor eye-using, and it showed that the light exposure intensity of myopic students is lower than that of non-myopia students. Studies have found that the light wave bandwidth has a significant impact on the emmetropization of the eye, and white light can promote emmetropia more than monochromatic light. It shows that outdoor exercise has a protective effect on the occurrence and development of myopia in children and adolescents, but the specific mechanism is still unclear. Retinal blood flow is sensitive to myopic stimuli, and is a short-term indicator of the relationship between light environment and myopia. This study selected retinal blood flow as the primary outcome, aiming to compare the effects of different outdoor light exposure modes on retinal blood flow after 1 hour of intense eye use, and provide clues for the prevention and control of myopia.

NCT ID: NCT05538754 Completed - Myopia Clinical Trials

Post-Market Evaluation of the EVO ICL

Start date: September 23, 2022
Phase: N/A
Study type: Interventional

The objective of this study is to assess the rate of early intraocular pressure (IOP) increases following implantation of EVO/EVO+ Implantable Collamer Lens (ICL).

NCT ID: NCT05501795 Completed - Myopia Clinical Trials

The Accuracy of Flap Thickness Versus the Pre-determined Surgical Planning Using WaveLight® FS200

Start date: August 9, 2022
Phase:
Study type: Observational

The objective is to evaluate the resultant thickness of the FS200 created LASIK flap compared to plan at the surgical visit.

NCT ID: NCT05483127 Completed - Myopia Clinical Trials

Clinical Comparison of Two Daily Disposable Toric Soft Contact Lenses

Start date: September 13, 2022
Phase: N/A
Study type: Interventional

The primary purpose of this study is to demonstrate noninferiority in the visual acuity at distance when wearing PRECISION1™ for Astigmatism (P1fA) soft contact lenses compared to another commercially available, soft toric contact lens, MyDay® toric (MDT).

NCT ID: NCT05470881 Completed - Myopia Clinical Trials

Phase I Clinical Trial to Evaluate the Safety and Tolerability of Ophtalmic Solution PRO-201

PRO-201
Start date: August 20, 2022
Phase: Phase 1
Study type: Interventional

Evaluation of the safety and tolerability of PRO-201 (0.01% sulfate atropine) after its instillation on the ocular surface of healthy volunteers through the following variables: unexpected adverse events incidence and photophobia (primary outcome variables); as well as pupillary diameter, expected adverse events incidence, best near corrected visual acuity (BNCVA), best corrected visual acuity (BCVA), intraocular pressure (IOP), corneal and conjunctival staining, heart rate, blood pressure and ocular confort index (OCI),

NCT ID: NCT05438615 Completed - Myopia Clinical Trials

Corneal Refractive Therapy Design Comparison for -4 to -6 Diopter Treatment for Overnight Wear for Myopia

Start date: December 2015
Phase: N/A
Study type: Interventional

The primary objective of this study is to compare the effectiveness of two proximity control geometry lens designs to treat eyes with pretreatment myopia between -4.00 and -6.00 D myopia with and without refractive astigmatism in a modality involving overnight wearing.

NCT ID: NCT05431868 Completed - Cataract Clinical Trials

Objective and Subjective Outcomes of a Trifocal IOL in Eyes With Different AL

Start date: January 1, 2019
Phase:
Study type: Observational

This prospective cohort study enrolled patients with implantation of a trifocal IOL. Only one eye of each patient was enrolled. Eyes were devided into three groups according the axial length (AL), including the short AL group, the control group and the long AL group. Manifest refraction, uncorrected and distance-corrected visual acuity at different distances, contrast sensitivity, aberrations and IOL decentration were measured three months after surgery. Spectacle independence, adverse photic phenomena, overall satisfaction and life quality were assessed with a questionnaire.